VEEA INC. 10-Q

Item 1. Financial Statements VEEA INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, December 31, 2025 2024 (unaudited) ASSETS Cash $ 247,341 $ 1,685,633 Receivables, net 82,128 84,655 Inventory, net 7,777,249 7,459,240 Prepaid and other current assets 5,553,840 5,649,594 Total current assets 13,660,558 14,879,122 Property and equipment, net 171,371 210,629 Goodwill 4,924,151 4,779,625 Intangible assets, net 898,052 786,061 Investments 235,666 235,596 Other assets 117,231 202,862 TOTAL ASSETS $ 20,007,029 $ 21,093,895 LIABILITIES AND STOCKHOLDERS’ DEFICIT Revolving line of credit $ 14,000,000 $ 12,700,000 Accounts payable 3,913,079 1,290,824 Accrued expenses 1,039,096 1,911,722 Related party accrued rent 3,790,800 3,657,600 Share issuance liability 350,000 250,000 Deferred payables, current 2,295,339 204,445 Other current liabilities 30,463 121,579 Total current liabilities 25,418,777 20,136,171 Related party notes 485,000 - Convertible note payable, net 327,679 37,316 Conversion option liability 1,000 60,000 Warrant liability 420,497 840,995 Earn-out Share Liability 5,030,000 15,560,000 Deferred payables - 1,484,238 TOTAL LIABILITIES 31,682,953 38,118,720 STOCKHOLDERS’ DEFICIT Preferred stock, $ 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding - - Common Stock, $ 0.0001 par value, 500,000,000 shares authorized; and 36,541,882 and 36,202,798 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 3,655 3,621 Additional paid-in capital 201,697,086 200,667,682 Accumulated deficit ( 213,531,466 ) ( 217,830,518 ) Accumulated other comprehensive income 154,802 134,391 TOTAL STOCKHOLDERS’ DEFICIT ( 11,675,924 ) ( 17,024,825 ) TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 20,007,029 $ 21,093,895 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 1 VEEA INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) For the Three Months Ended March 31, 2025 2024 Sales, net $ 14,262 $ 16,770 Cost of goods sold 12,330 11,984 Gross profit 1,932 4,786 Operating Expenses: Product development 215,575 94,223 Sales and marketing 349,251 86,264 General and administrative, net 5,109,473 5,845,775 Transaction costs 35,000 - Depreciation and amortization 60,116 68,916 Total operating expenses 5,769,415 6,095,178 Loss from operations ( 5,767,483 ) ( 6,090,392 ) Other income (expense): Other income, net 772 2,584 Change in fair value of convertible note option liability 59,000 - Change in fair value of warrant liabilities 420,497 - Change in fair value of Earn-out Share Liability 10,530,000 - Other expense 2,750 ( 2,836 ) Interest expense ( 946,484 ) ( 456,768 ) Total other income (expense) 10,066,534 ( 457,020 ) Net income (loss) $ 4,299,052 $ ( 6,547,412 ) Net income (loss) per share: Basic $ 0.12 $ ( 0.31 ) Diluted $ 0.12 $ ( 0.31 ) Weighted-average common stock outstanding used in per share amounts: Basic 36,369,224 21,115,617 Diluted 36,583,665 21,115,617 Other comprehensive income (loss): Foreign currency translation adjustment 20,411 365,381 Comprehensive income (loss) $ 4,319,462 $ ( 6,182,031 ) The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 2 VEEA INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Unaudited) FOR THE THREE MONTHS ENDED MARCH 31, 2025 Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Total Stockholders’ Shares Amount Capital Deficit Income (Loss) Deficit Balance, December 31, 2024 36,202,798 $ 3,621 $ 200,667,682 $ ( 217,830,518 ) $ 134,391 $ ( 17,024,824 ) Stock based compensation 50,000 50,000 Common stock issued upon exercise of stock options 24,420 2 8.67 11 Common stock issued upon draw on the equity line of credit 240,500 24 604,402 604,426 Common stock issued as compensation for equity line of credit commitment fee 27,498 3 24,997 25,000 Settlement of convertible note agreement for shares issued 46,666 5 349,995 350,000 Cumulative translation adjustment 20,411 20,411 Net income 4,299,052 4,299,052 Balance, March 31, 2025 36,541,882 $ 3,655 $ 201,697,086 $ ( 213,531,466 ) $ 154,802 $ ( 11,675,924 ) FOR THE THREE MONTHS ENDED MARCH 31, 2024 Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Total Stockholders’ Shares Amount Capital Deficit Income (Loss) Deficit Balance, December 31, 2023 19,635,912 $ 1,964 $ 159,475,010 $ ( 170,282,750 ) $ ( 661,354 ) $ ( 11,467,130 ) Series A-2 Preferred Stock Issuances, net of transaction costs 1,675,502 168 11,955,239 11,955,407 Conversion of vendor payable to Series A-2 Preferred Stock 10,456 1 78,422 78,423 Stock based compensation for stock options 62,670 62,670 Foreign currency translation (loss) 365,381 365,381 Net loss ( 6,018,994 ) ( 6,018,994 ) Balance, March 31, 2024 21,321,870 $ 2,133 $ 171,571,341 $ ( 176,301,744 ) $ ( 295,973 ) $ ( 5,024,243 ) The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 3 VEEA INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Three Months Ended March 31, 2025 2024 Cash flows from operating activities Net income (loss) $ 4,299,052 $ ( 6,547,412 ) Adjustments to reconcile net income (loss) to net cash used for operating activities: Depreciation and amortization 60,116 68,916 Amortization of debt issuance costs 740,363 - Change in fair value of convertible note option liability ( 59,000 ) - Change in fair value of warrant liabilities ( 420,497 ) - Change in fair value of Earn-out Share Liability ( 10,530,000 ) - Common stock issued as compensation for ELOC commitment fee 25,000 - Share based compensation 50,000 62,670 Unrealized foreign currency transaction loss 340,728 358,517 Amortization of operating lease right of use assets 87,956 166,546 Changes in operating assets and liabilities: Receivables 18,259 ( 17,237 ) Inventories ( 318,475 ) ( 62,996 ) Prepaid and other current assets 100,491 ( 4,904,725 ) Other assets ( 1,699 ) Accounts payable 2,222,819 58,877 Accrued expenses ( 829,394 ) ( 98,561 ) Accrued interest - 367,210 Other current liabilities 606,656 - Operating lease payments ( 91,116 ) ( 146,500 ) Net cash used in operating activities ( 3,698,741 ) ( 10,694,695 ) Cash flows from investing activities Purchase of property and equipment - ( 29,520 ) Purchase of intangible assets and trademarks ( 131,973 ) ( 44,547 ) Net cash used in investing activities ( 131,973 ) ( 74,067 ) Cash flows from financing activities Proceeds from revolving line of credit 1,300,000 - Proceeds from related party notes 485,000 - Proceeds from the issuance of shares under equity line of credit facility 604,426 - Proceeds from the issuance of Series A-2 preferred stock, net of transaction costs - 10,372,477 Proceeds from prepaid investor subscriptions - 54,725 Proceeds from exercise of stock options 11 - Net cash provided by financing activities 2,389,437 10,427,202 Effect of exchange rate changes on cash 2,985 ( 19,706 ) Net decrease in cash and cash equivalents ( 1,438,292 ) ( 361,266 ) Cash and cash equivalents at beginning of year 1,685,633 6,010,075 Cash and cash equivalents at end of year $ 247,341 $ 5,648,809 Non-cash activities Settlement of convertible notes for shares issued $ 350,000 - Conversion of vendor payable to Series A-2 Preferred Shares $ - $ 78,422 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 4 Veea Inc. and Subsidiaries Notes to the Condensed Consolidated Financial Statements 1 - DESCRIPTION OF BUSINESS The Company is a provider of edge computing and communications devices (i.e., “VeeaHub Ò ” devices), applications, and services hosted on its edge Platform-as-a-Service (“ePaaS”). Veea Edge Platform ePaaS is an end-to-end platform that is both locally- and cloud-managed. VeeaHub Ò products are converged computing and communications (i.e., hyperconverged) indoor and outdoor devices, about the size of a Wi-Fi Access Point (AP), that provide for networking and computing solutions for AI-assisted applications and solutions at the edge where people, places, and things connect to the network. Veea Edge Platform Ô provides for highly secure connectivity, computing, and IoT solutions through full stack platform for digital transformation of industries, as well as unserved or underserved communities that lack Internet connectivity and essential applications and services. It further enables the formation of highly secure, but easily accessible, private clouds and networks across one or multiple user(s) or enterprise location(s) across the globe. We have redefined and simplified edge computing and connectivity with Veea Edge Platform Ô , easily deployable products that fully integrate hardware, system software, technologies, and edge applications. We are demonstrating, globally, that the Veea Edge Platform Ô enables our partners and customers to champion digital transformations in multiple vertical markets. Through our innovative Veea Edge Platform, we have created a new product category that brings cloud capabilities close to the user, as an alternative to cloud computing, with benefits in optimal latency, lower data transport costs, data privacy, security and ownership, Edge AI, “always-on” availability at the edge for mission critical applications, and contextual awareness for people, devices and things connected to the Internet. The Company was recognized in 2023 by Gartner as a Leading Smart Edge Platform for the innovativeness and capabilities of our Veea Edge Platform and a Cool Vendor in Edge Computing in 2021. Veea was named in Market Reports World’s research report published in October 2023 as one of the top 10 Edge AI solution providers alongside IBM, Microsoft, Amazon Web Services, and others. On September 13, 2024, Plum Acquisition Corp. I. (“Plum”), a special purpose acquisition company, and VeeaSystems Inc., a Delaware corporation (“Private Veea”), consummated a business combination (the “Business Combination”), pursuant to that certain Business Combination Agreement, dated November 27, 2023 (as amended on June 13, 2024 and September 13, 2024, the “Business Combination Agreement”), between Plum, Private Veea, and Plum Merger Sub, a Delaware corporation) (“Plum Merger Sub”). In connection with the consummation of the Business Combination (the “Closing”), (i) Plum de-registered from the Register of Companies in the Cayman Islands by way of continuation out of the Cayman Islands and into the State of Delaware, migrating to and domesticating as a Delaware corporation (the “Domestication”) and (ii) the merger (the “Merger”) of Plum Merger Sub with and into Private Veea was completed and the separate corporate existence of Plum Merger Sub ceased, with Private Veea as the surviving corporation becoming a wholly owned subsidiary of Plum. Following the Closing, Plum changed its name from “Plum Acquisition Corp. I” to “Veea Inc.” (hereinafter “Veea” or “the Company”) and Private Veea changed its name from “Veea Inc.” to “VeeaSystems Inc.” See Note 4 for more information. The Company has five wholly owned subsidiaries: VeeaSystems Inc., formerly known as Veea Inc., a Delaware corporation; Veea Solutions Inc., a Delaware corporation; VeeaSystems Development Inc., formerly known as Veea Systems Inc., a Delaware corporation; Veea Systems Ltd., a company organized under the laws of England and Wales; and VeeaSystems SAS, a French simplified joint stock company; and one majority owned subsidiary, VeeaSystems Mexico, S. de R.L. de C.V., a limited capital company organized under the laws of Mexico (“VeeaSystems MX”). VeeaSystems MX is 95 % owned by VeeaSystems Inc., and due to local law requirements, the remaining 5 % is held by the Company’s CEO. The Company is headquartered in New York City with offices in the United States, Mexico, and Europe. 5 2 - LIQUIDITY AND MANAGEMENT’S PLAN During the three months ended March 31, 2025 and 2024, the Company incurred operating losses of $ 5.7 million and $ 6.1 million, respectively, and had an accumulated deficit of $ 213.5 million as of March 31, 2025. Since its inception, the Company has incurred significant operating losses and negative cash flows. The Company expects to continue to incur net losses as it continues to grow and scale its business. As of March 31, 2025, the Company had cash of $ 247,341 and outstanding debt of $ 15.2 million, of which $ 750,000 was outstanding under the September 2024 Notes (as defined below), $ 14.0 million was outstanding under the working capital facility, and $ 485,000 was related party debt outstanding under the NLabs 2025 Notes (as defined below). Although the Company has had recurring losses each year since inception, the Company plans to fund its operations and capital funding needs through a combination of private and public equity and debt offerings, or a combination thereof, including (1) cash proceeds from the ELOC Program (as defined below) (2) the expected cash tax refund of up to $ 2.0 million in respect of the Company’s UK subsidiary’s 2023 and 2024 research and development activities (3) the anticipated refund by June 30, 2025, of up to $ 5.0 million of the Company’s prepayment for purchased inventory and (4) potential additional investments in the form of debt or equity to fund operating deficits from existing and/or new investors, including related parties, which may include the Company’s CEO and his affiliates. The Company expects it will be able to fund its operations over the next twelve months and has a reasonable basis to believe it has alleviated substantial doubt regarding its ability to continue as a going concern. Since January 1, 2025, the Company has received $ 826,000 in additional loans from related parties and $ 1.0 million in loans from unrelated parties in connection with the consummation of the acquisition of Crowdkeep. See Note 12 and Note 17 for additional information. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company, if at all. 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial information. Accordingly, certain information and footnote disclosures normally included in consolidated financial statements in accordance with GAAP have been omitted. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All significant intercompany balances and transactions have been eliminated in consolidation. We consolidate any variable interest entity (“VIE”) where we have determined we are the primary beneficiary. The primary beneficiary is the entity which has both: (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and (ii) the obligation to absorb losses or receive benefits of the entity that could potentially be significant to the VIE. The Company has one VIE, VeeaSystems MX. Transactions with VeeaSystems MX were immaterial during all the period presented and are not separately disclosed. The condensed consolidated balance sheet as of March 31, 2025, has been derived from the unaudited consolidated financial statements at that date, but does not include all disclosures, including notes, required by GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for its year ended December 31, 2024. Basis of Accounting The accompanying condensed consolidated financial statements have been prepared on the accrual basis in accordance with accounting principles generally accepted under GAAP. 6 Use of Estimates Management of the Company is required to make certain estimates, judgments, and assumptions during the preparation of its condensed consolidated financial statements in accordance with GAAP. The Company believes that these estimates, judgments and assumptions are reasonable under the circumstances. These estimates, judgments, and assumptions impact the reported amounts of assets, liabilities, revenue, and expenses, and the related disclosure of contingent assets and liabilities. Actual results could differ from these estimates. Changes in such estimates could affect amounts reported in future periods. On an ongoing basis, the Company evaluates its estimates and judgments including those related to: liquidity and going concern, the useful lives and recoverability of property and equipment and definite-lived intangible assets; the recoverability of goodwill and indefinite-lived intangible assets; the carrying value of accounts receivable, including the determination of the allowance for credit losses; inventory, including the determination of allowances for estimated excess or obsolescence; the fair value of warrants; the fair value of acquisition-related contingent consideration arrangements; the fair value of the ELOC; unrecognized tax benefits; legal contingencies; the incremental borrowing rate for the Company’s leases; and the valuation of stock-based compensation, among others. Emerging Growth Company Status The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. Segment Information The Company operates as a single operating segment. The chief operating decision maker is the Company’s Chief Executive Officer, who makes resource allocation decisions and assesses performance based on financial information presented on a consolidated basis, accompanied by disaggregated revenue information. Accordingly, the Company has determined that it has a single reportable segment and operating segment. The majority of the Company’s assets as of March 31, 2025 and December 31, 2024, were attributable to its U.S. operations. The Company does not have any customers that make up more than 10 % of revenue, and its long-lived assets are based on the physical location of the assets. Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024, on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance results in the Company being required to include enhanced income tax-related disclosures. The Company adopted this guidance effective January 1, 2025; however, as there is a full valuation allowance on its deferred tax assets, income tax disclosures are not material to the condensed consolidated financial statements and are not included in this Quarterly Report on Form 10-Q but will be evaluated quarterly going forward necessary disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . This ASU includes amendments that expand the existing reportable segment disclosure requirements and requires disclosure of (i) significant expense categories and amounts by reportable segment as well as the segment’s profit or loss measure(s) that are regularly provided to the chief operating decision maker (the “CODM”) to allocate resources and assess performance; (ii) how the CODM uses each reported segment profit or loss measure to allocate resources and assess performance; (iii) the nature of other segment balances contributing to reported segment profit or loss that are not captured within segment revenues or expenses; and (iv) the title and position of the individual or name of the group or committee identified as the CODM. This guidance requires retrospective application to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The adoption of this guidance results in the Company being required to include enhanced disclosures relating to its reportable segments. The Company adopted this guidance effective December 31, 2024, and it did not have a material effect on the Company’s condensed consolidated financial statements. 7 4 - REVERSE RECAPITALIZATION As discussed in Note 1, the Business Combination was consummated on September 13, 2024, which, for accounting and reporting purposes under GAAP, was treated as the equivalent of Private Veea issuing stock for the net assets of Plum, accompanied by an equity recapitalization of Private Veea, which was determined to fall within the scope of Accounting Standards Codification (“ASC”) 805, “ Business Combinations ”. Plum was treated as the acquired company, and its net assets were stated at historical cost, with no goodwill or other intangible assets recorded. The excess of the fair value of shares issued to Plum over the fair value of Plum’s identifiable net assets acquired represented compensation for the service of a stock exchange listing for its shares and was expensed as incurred. The warrants issued at the time of Plum’s initial public offering (the “Public Warrants”), and warrants issued in connection with private placement at the time of Plum’s initial public offering (the “Private Placement Warrants”) remain outstanding and are now outstanding warrants for the Company. Earn-out Share Liability Following the Closing, stockholders who previously held certain capital stock of Private Veea have the contingent right to receive up to 4.5 million additional shares of the common stock, par value $ 0.0001 per share, of the Company (“Common Stock”) if certain trading-price based milestones of the Company’s Common Stock are achieved or a change of control transaction occurs during the ten-year period following the Closing. Under accounting principles, the Company’s obligation to issue the earn-out shares is recorded as a contingent liability (the “Earn-out Share Liability”) in the Company’s financial statements and the initial value of the Earn-out Share Liability was recorded as a transaction cost within operating expenses in the Company’s financial statements for the year ended December 31, 2024. For each subsequent reporting period, changes in the fair value of the Earn-out Share Liability are reported in the Company’s financial statements. 5 - BALANCE SHEET COMPONENTS Inventory Inventory consists of the following: March 31, 2025 December 31, 2024 Inventory $ 7,256,166 $ 7,377,966 Inventory allowance ( 904,653 ) ( 904,653 ) Consigned parts 1,425,736 985,927 Total $ 7,777,249 $ 7,459,240 Property and Equipment, net Property and equipment, net consists of the following: March 31, 2025 December 31, 2024 Furniture and fixtures $ 703,101 $ 702,122 Computer equipment 330,598 327,166 Leasehold improvements 390,742 390,742 Total property and equipment gross 1,424,441 1,420,030 Less - Accumulated depreciation ( 1,253,070 ) ( 1,209,401 ) Total property and equipment net $ 171,371 $ 210,629 Depreciation expense for the three months ended March 31, 2025 and 2024, totaled $ 35,697 and $ 54,851 , respectively. 8 6 - GOODWILL AND INTANGIBLE ASSETS Goodwill The following is a summary of activity in goodwill for the three months ended March 31, 2025 and 2024: March 31, 2025 Balance at December 31, 2024 $ 4,779,625 Foreign exchange transactions 144,526 Balance at March 31, 2025 4,924,151 March 31, 2024 Balance at December 31, 2023 $ 4,797,078 Foreign exchange transactions 16,156 Balance at March 31, 2024 4,813,234 Intangible Assets Intangible assets consist of the following: As of March 31, 2025 Amortization Period Costs as of December 31, 2024 Additions Disposals Ending Costs Accumulated Amortization Accumulated Impairment Net Book Value Patents 15 years $ 7,551,468 $ 130,991 - 7,682,459 ( 6,784,407 ) - $ 898,052 As of December 31, 2024 Amortization Costs as of January 1, Ending Accumulated Accumulated Net Book Period 2024 Additions Disposals Costs Amortization Impairment Value Patents 15 years $ 7,332,227 $ 219,241 $ - $ 7,506,485 $ ( 6,765,407 ) $ - $ 786,061 IPR&D 5 years 5,015,694 - - 5,015,694 ( 3,554,784 ) ( 1,460,910 ) - Other intellectual assts 5 years 969,278 - - 969,278 ( 969,278 ) - - Intangible assets, net $ 13,317,199 $ 219,241 $ - $ 13,536,440 $ ( 11,289,469 ) $ ( 1,460,910 ) $ 786,061 Intangible assets primarily consist of patents, patent applications, and in-process research and development (“IPR&D”) and other identifiable intangible assets. Intangible assets are generally amortized on a straight-line basis over the periods of benefit. The Company’s patents have estimated remaining economic useful lives ranging from 5 - 15 years. Management reviews intangible assets for impairment when events and circumstances warrant. During the three months ended March 31, 2025 and 2024, there were no events that necessitated additional impairment of intangible assets. Intangible asset amortization expense for the three months ended March 31, 2025 and 2024, totaled $ 19,000 and $ 14,065 , respectively. 9 Future estimated amortization expense for the Company’s intangible assets is approximately as follows: Future estimated amortization as of March 31, 2025 Remainder of 2025 $ 57,000 2026 76,000 2027 76,000 2028 76,000 2029 76,000 Thereafter 537,052 $ 898,052 7 - DEBT Total outstanding debt of the Company is comprised of the following, including convertible notes and other related party debt: March 31, 2025 Principal Debt Discount Accrued Interest Total Revolving Loan Facility $ 14,000,000 $ - $ - $ 14,000,000 Convertible note payable 750,000 ( 422,321 ) - 327,679 Total $ 14,750,000 ( 422,321 ) $ 14,327,679 December 31, 2024 Principal Debt Discount Accrued Interest Total Revolving Loan Facility $ 12,700,000 $ - $ - $ 12,700,000 Convertible note payable 1,200,000 ( 1,102,684 ) - 97,316 Total $ 13,900,000 $ ( 1,102,684 ) $ - $ 12,797,316 Revolving Loan Facility In June 2021, Private Veea entered into a revolving loan agreement (the “2021 Revolving Loan Agreement”) with First Republic Bank, which was subsequently acquired by JPMorgan Chase, (the “Bank”) providing up to $ 14.0 million of advances (collectively, the “Loan”). The Loan accrues interest at a variable rate based on an index rate established by reference to the average 12 -month trailing one-year US treasuries plus a spread of 1.80 % per annum and a minimum floor rate of 1.5 % per annum. Interest is payable monthly in cash. Private Veea was not required to provide collateral for the advances or comply with any covenants. The advances were secured by a lien on certain personal assets of the CEO. In consideration for the security provided by the CEO, Private Veea issued common stock warrants (the “Related Party Common Stock Warrants”) to NLabs, a principal shareholder of the Company and affiliate of Allen Salmasi (“NLabs”), in consideration for the CEO’s guaranteeing the advances. See Note 12 for further information. In December 2023, Private Veea repaid $ 5,000,000 of the principal balance of the Loan. Following the acquisition of First Republic, the Loan was transferred to the Bank. Total borrowings during the three months ended March 31, 2025, were $ 1.3 million. As of March 31, 2025, the outstanding principal amount of the Loan was $ 14.0 million, and there is no availability to borrow additional funds. Convertible Note Payable Simultaneously with the closing of the Business Combination, the Company and Private Veea issued convertible notes under note purchase agreements (the “Note Purchase Agreements”) with certain accredited investors unaffiliated with the Company and Private Veea (each, an “Investor”) for the sale of unsecured subordinated convertible promissory notes (the “September 2024 Notes”) as part of a private placement offering of up to $ 15.0 million in purchase price for such September 2024 Notes in the aggregate (the “Financing Closing”). The Company received $ 1.45 million in proceeds from the issuance of its convertible promissory notes. In addition to a September 2024 Note, each Investor received, as a transfer from NLabs immediately prior to the Financing Closing, a number of shares of Private Veea’s Series A-1 Preferred Stock that upon the Closing became a number of registered shares of Common Stock equal to such Investors’ original principal note loan amount under their respective notes divided by $ 7.50 (the “Transferred Shares”). 2.0 million Transfer Shares were delivered to Investors at the Financing Closing. The Note Purchase Agreements include customary registration rights. 10 The Transferred Shares were recorded at a fair value of $ 21.6 million on the Company’s consolidated financial statements at issuance, which reflected a significant discount to the face amount of the September 2024 Notes. In addition to the cash received at the Financing Closing, one of the Investors committed to purchase approximately $ 13.6 million (the “Commitment Amount”) of September 2024 Notes, on or prior to November 15, 2024, which date was subsequently extended to December 15, 2024. On December 31, 2024, the Company and one of the Investors entered into a mutual Settlement and Release Agreement pursuant to which the Company agreed to terminate the Investor’s obligation to purchase a note in the Commitment Amount and provided for a mutual release of claims, in exchange for a payment to the Company of an aggregate amount of approximately $ 5.4 million, which amount includes payments previously made to the Company in respect of the Commitment Amount. As the Company received approximately $ 1.5 million of the total expected $ 15.0 million proceeds at the Financing Closing, a proportional amount (approximately $ 19.5 million) of the substantial discount was deferred and recorded as a deferred financing asset on the Company’s consolidated financial statements. At December 31, 2024, the deferred financing assets were reversed on the Company’s consolidated financial statements. The Company and VeeaSystems Inc. (“VeeaSystem”) are co-borrowers under each September 2024 Note (together, the “Borrowers”) and are jointly responsible for the obligations to each Investor thereunder. Each September 2024 Note has a maturity date of 18 months after the Financing Closing but is prepayable in whole or in part by the Borrowers at any time without penalty. The outstanding obligations under each September 2024 Note accrues interest at a rate equal to the Secured Overnight Financing Rate plus 2 % per annum, adjusted quarterly, but interest is only payable upon the maturity date of the September 2024 Note as long as there is no event of default thereunder. Each September 2024 Note is unsecured and expressly subordinated to any senior debt of the Borrowers. The September 2024 Notes and the Note Purchase Agreements do not include any operational or financial covenants for the Borrowers. Each September 2024 Note includes customary events of default including, without limitation, failure to pay amounts due on the maturity date, failure to otherwise comply with the Borrowers’ covenants or for Borrower insolvency events, in each case, with customary cure periods. Upon an event of default, the Investor may accelerate all obligations under its September 2024 Note and the Borrowers will be required to pay for the Investor’s reasonable out-of-pocket collection costs. The outstanding obligations under each September 2024 Note are convertible in whole or in part into shares of Common Stock (the “Conversion Shares”) at a conversion price of $ 7.50 per share (subject to equitable adjustment for stock splits, stock dividends and the like with respect to the Common Stock after the Financing Closing) (the “Conversion Price”) at any time after the Financing Closing at the sole election of the Investor. The outstanding obligations under each September 2024 Note will automatically convert at the Conversion Price if (i) the Company or its subsidiaries consummate one or more additional financings for equity or equity-linked securities for at least $ 20 million in the aggregate or makes one or more significant acquisitions valued in the aggregate (based on the consideration provided by the Company and its subsidiaries) to be at least $ 20 million, (ii) the Investors holding a majority of the aggregate outstanding obligations under the September 2024 Notes expressly agree to convert all obligations under the September 2024 Notes or (iii) the Common Stock trades with an average daily VWAP of at least $ 10.00 (subject to equitable adjustment for stock splits, stock dividends and the like with respect to the Common Stock after the Financing Closing) for ten (10) consecutive trading days . The obligations under each September 2024 Note will also automatically convert in connection with a Brokerage Transfer, as described below. The Conversion Shares were initially subject to a lock-up for a period of 6 months after the Financing Closing. The Transferred Shares were not subject to any lock-up restrictions, but for a period of 6 months after the Closing they were separately designated by the Transfer Agent and kept as book entry shares on the Transfer Agent’s records and were not be eligible to be held by DTC without the Investor first notifying the Company of its intent to transfer any such Transferred Shares to a brokerage account and/or to be held by DTC or another nominee (a “Brokerage Transfer”). If the Investor provided such notice or otherwise has any Transferred Shares subject to a Brokerage Transfer within 6 months after the Closing, a portion of the outstanding obligations under such Investor’s Note would automatically convert into a number of Conversion Shares equal to the number of Transferred Shares subject to such Brokerage Transfer, and the lock-up period for such Conversion Shares would be extended for an additional 6 months to 12 months after the Financing Closing. As of March 31, 2025, $ 750,000 in aggregate principal amount of the September 2024 Notes, together with associated interest, had automatically converted upon the occurrence of a Brokerage Transfer. 11 The Company reviewed the conversion feature granted in the notes under ASC 815, “ Derivatives and Hedging ” (“ASC 815”), and concluded that the conversion price was based on a variable (enterprise value) that was not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815 - 40 and is therefore considered a conversion option liability that should be bifurcated from the debt host. As the fair value of the conversion option liability exceeded the net proceeds received, in accordance with ASC 470-20, the Company recorded the conversion option liability at fair value with the excess of the fair value over the net proceeds received recognized as a loss in earnings. See Note 14 for further information. 8 - INVESTMENTS The Company accounts for its private company investments without readily determinable fair values under the cost method. These investments, for which the Company is not able to exercise significant influence over any one individual investee, is measured and accounted for using an alternative measurement basis of a) the security’s carrying value at cost, b) less any impairment and c) plus or minus any qualifying observable price changes. Observable price changes or impairments recognized on the Company’s private company investments would be classified as a Level 3 financial instrument within the fair value hierarchy based on the nature of the fair value inputs. Any adjustments to the carrying values are recognized in other income, net in the Company’s consolidated statements of operations and comprehensive loss. As of December 31, 2024, the Company performed the qualitative assessment for impairment of its investments. Based on this qualitative assessment, impairment indicators were present for one of its investments; therefore, the company performed an analysis to estimate its fair value and recognized an impairment loss of $ 216,278 . As of March 31, 2025, there were no indicators of impairment. The carrying value of the Company’s private company investments as of March 31, 2025 and December 31, 2024, was $ 235,666 and $ 235,596 , respectively, which were classified as Investments on the Company’s consolidated balance sheets, as these investments do not have a stated contractual maturity date. 9 – STOCKHOLDERS’ EQUITY On September 13, 2024, the Company consummated the Business Combination which was accounted for as a reverse recapitalization. In connection with the consummation of the Business Combination (i) the Company de-registered from the Register of Companies in the Cayman Islands by way of continuation out of the Cayman Islands and into the State of Delaware, migrating to and domesticating as a Delaware corporation (the “Domestication”) and (ii) restated our certificate of incorporation (“Restated Certificate of Incorporation”). In connection with the Domestication, each share of outstanding Class A ordinary shares were converted by operation of law into shares of Common Stock, on a one-for-one basis. Upon filing of the Restated Certificate of Incorporation, each issued and outstanding share of Class B stock outstanding immediately prior to the filing of the Restated Certificate of Incorporation was converted into shares of Common Stock on a one-for-one basis. Under the Restated Certificate of Incorporation, the Company is authorized to issue 551,000,000 shares of capital stock, consisting of (a) 550,000,000 shares of Common Stock with a par value of $ 0.0001 per share and (b) 1,000,000 shares of preferred stock with a par value of $ 0.0001 per share. Holders of Common Stock are entitled vote on all matters submitted to the stockholders vote or approval, other than on any amendment to the Restated Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon pursuant to the Restated Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock). Holders of Common Stock are entitled to one vote per share on all matters submitted to the stockholders for their vote or approval. 12 Equity Line of Credit On December 2, 2024, the Company entered into a common stock purchase agreement (“Common Stock Purchase Agreement”) and related registration rights agreement (the “Registration Rights Agreement”) with White Lion Capital, LLC (“White Lion”). Pursuant to the Common Stock Purchase Agreement, the Company has the right, but not the obligation, to direct White Lion to purchase up to $ 25.0 million in aggregate gross purchase price of newly issued shares of Common Stock, subject to certain limitations and conditions as described below (the “ELOC Program”), at a purchase price equal to (i) 96.5 % of the volume weighted average stock price for the three consecutive business days after a purchase notice is given, (ii) 98 % of the volume weighted average stock price on the day a notice is delivered, or (iii) the lowest traded price for a given purchase date. The Company controls the timing and amount of any sales to White Lion, which depend on a variety of factors including, among other things, market conditions, the trading price of the Common Stock, and determinations by the Company as to appropriate sources of funding for its business and operations. However, White Lion’s obligation to purchase shares is subject to certain conditions, including the daily trading volume of the Company’s stock. In all instances, the Company may not sell shares of Common Stock under the Purchase Agreement if it would result in White Lion and its affiliate beneficially owning more than 4.99 % of its outstanding voting power or shares of the Common Stock at any one point in time, or the aggregate number of shares of common stock would not exceed 19.99 % of the voting power of the issued and outstanding Common Stock. During the three months ended March 31, 2025, the Company received $ 604,426 in proceeds and issued 240,500 shares of Common Stock pursuant to the ELOC Program. The Company agreed to issue to White Lion 27,498 shares of Common Stock as a commitment fee (the “Commitment Shares”). The fair value of the Commitment Shares was $ 25,000 , which pursuant to ASC 815, was recorded in transaction costs in the condensed consolidated statement of operations and comprehensive income (loss) during the three months ended March 31, 2025. The Common Stock Purchaser has agreed that during the term of the Common Stock Purchase Agreement, neither it nor any of its affiliates will engage in any short sales or hedging transactions involving the Common Stock. 10 - STOCK INCENTIVE PLANS In September 2014, the Private Veea’s Board of Directors adopted the Max2 Inc. Equity Incentive Plan (“2014 Plan”). Upon adoption of the 2014 Plan, the aggregate number of shares of Common Stock reserved for awards under the Plan were 1,250,000 . In September 2018, Private Veea’s Board of Directors adopted the Veea Inc. 2018 Equity Incentive Plan (“2018 Plan” and collectively with the 2014 Plan, the “Private Veea Plans”). Upon adoption of the 2018 Plan, 4,900,000 shares of the Common Stock were reserved for the issuance of incentive awards. In January 2021, the 2018 Plan was amended to increase the total number of authorized shares reserved for issuance to 12,492,910 . Under the Private Veea Plans, option awards were generally granted with an exercise price equal to the fair market value of the Company’s stock at the date of grant; those option awards generally vested with a range of one to four years of continuous service and had ten-year contractual terms. Certain option awards provided for accelerated vesting if there was a change in control, as defined in the Private Veea Plans. The Private Veea Plans also permitted the granting of restricted stock and other stock-based awards. Unexercised options were cancelled upon termination of employment and became available for reissuance under the Private Veea Plans. On June 4, 2024, the stockholders of the Company approved the Veea Inc. 2024 Incentive Award Plan (the “2024 Incentive Plan”, collectively with the Private Veea Plans, the “Plans”), which became effective upon the Closing. The Company initially reserved 4,460,437 shares of Common Stock for the issuance of awards under the 2024 Incentive Plan (“Initial Limit”). The Initial Limit represented 10 % of the aggregate number of shares of the Common Stock outstanding immediately after the Closing plus the number of shares of Common Stock issuable under the 2014 Plan and the 2016 Plan and is subject to increase each year over a ten-year period. The 2024 Incentive Plan provides for the grant of stock options, which may be ISOs or non-statutory stock options (“NSOs”), stock appreciation rights (“SARs”), restricted shares, restricted stock units and other stock or cash-based awards that the Administrator determines are consistent with the purpose of the 2024 Incentive Plan. As of March 31, 2025, the Company had approximately 1,259,370 shares available for grant. 13 On June 4, 2024, the stockholders of the Company approved Veea Inc. 2024 Employee Stock Purchase Plan (the “ESPP”), which became effective upon the Closing. An aggregate of 1,070,603 shares of Common Stock has been reserved for issuance or transfer pursuant to rights granted under the ESPP (“Aggregate Number”). The Aggregate Number represented 3 % of the aggregate number of shares of Common Stock outstanding immediately after the Closing and is subject to increase each year over a ten-year period. The ESPP provides eligible employees with an opportunity to purchase Common Stock from the Company at a discount through accumulated payroll deductions. The ESPP will be implemented through a series of offerings of purchase rights to eligible employees. Under the ESPP, the Company’s Board of Directors may specify offerings but generally provides for a duration of 12 months. The purchase price will be specified pursuant to the offering, but cannot, under the terms of the ESPP, be less than 85 % of the lower of the fair market value per share of the Common Stock on either the offering date or on the purchase date. As of March 31, 2025, there have not yet been any offering periods available to purchase Common Stock under the ESPP. In connection with the Business Combination, each Private Veea option that was outstanding immediate prior to Closing, whether vested or unvested, was exchanged for a stock option under the 2024 Plan (each an “Exchanged Option”) to acquire a number of shares of Common Stock equal to the product of (i) the number of shares of Private Veea’s common stock subject to such Private Veea option immediately prior to the Business Combination and (ii) the Exchange Ratio, at an exercise price per share equal to (A) the exercise price per share of such Private Veea option immediately prior to the consummation of the Business Combination, divided by (B) the Exchange Ratio. Following the Business Combination, each Exchanged Option continues to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Private Veea option immediately prior to the consummation of the Business Combination. Unvested Private Veea options did not accelerate nor vest on the consummation of the Business Combination. All stock option activity was retroactively restated to reflect the effect of the Exchange Ratio. Generally, stock options vest 25 % on the first anniversary of the vesting commencement date and then quarterly thereafter for 12 quarters, or pursuant to another vesting schedule as approved by the Board and set forth in the option agreement. Stock options have a maximum term of ten years from the date of grant. The aggregate intrinsic value is the fair market value on the reporting date less the exercise price for each option. The fair value of each stock option award is estimated on the date of the grant using the Black-Scholes option-pricing model. For options granted during the three months ended March 31, 2025 and 2024, respectively, the weighted average estimated fair value using the Black-Scholes option pricing model was $ 1.16 and $ 0.55 per option, respectively. Stock Options Stock option activity under the Plan was as follows: Number of Options Weighted- Average Exercise Price per Share Weighted- Average Remaining Contractual Term (years) Outstanding at December 31, 2024 3,790,702 $ 1.04 5.98 Granted 30,000 1.82 - Exercised ( 24,420 ) - - Forfeited ( 12,245 ) 2.78 - Outstanding at March 31, 2025 3,784,037 $ 1.64 8.50 Exercisable at March 31, 2025 3,744,271 14 The fair value of each stock option granted is estimated using the Black-Scholes option-pricing model using the single-option award approach. The assumptions used to calculate the fair value of the options granted during the three months ended March 31, 2025, were as follows: March 31, 2025 Stock Price $ 1.82 Expected term (years) 5.0 Volatility 75.0 % Risk-Free Rate 4.12 % Stock compensation expense related to the common stock options outstanding for the three months ended March 31, 2025 and 2024, was $ 50,000 and $ 62,670 , respectively, which is included in general and administrative expenses in the Company’s condensed consolidated statements of operations and comprehensive income (loss). Total unrecognized expense related to unvested options outstanding as of March 31, 2025, was $ 135,863 which will be recognized over a weighted average period of 2.49 years. Restricted Stock Units There were no RSUs granted or stock compensation expense recorded during each of the three months ended March 31, 2025 and 2024. 11 - WARRANTS As part of Plum’s initial public offering (“IPO”), Plum issued warrants to third-party investors where each whole warrant entitles the holder to purchase one share of the Common Stock at an exercise price of $ 11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Plum completed the private sale of warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) where each Private Placement Warrant allows the holder to purchase one share of the Common Stock at $ 11.50 per share. At March 31, 2025, there were 6,384,326 Public Warrants and 5,256,218 Private Placement Warrants outstanding. The Public Warrants become exercisable at $ 11.50 per share, subject to adjustment, at any time commencing 30 days after the completion of the Business Combination; provided that the Company has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of the Business Combination, it shall use commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the warrants. Such registration statement was declared effective by the SEC on January 15, 2025. With the exception of the Private Placement Warrants, in no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the shares of Common Stock underlying such Warrant. 15 Redemption of Warrants When the Price per Share of Common Stock Equals or Exceeds $ 18.00 Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $ 0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price of our Common Stock equals or exceeds $ 18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30 -trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. Redemption of Warrants When the Price per Share of Common Stock Equals or Exceeds $ 10.00 Once the Warrants become exercisable, the Company may redeem the outstanding Warrants: ● in whole and not in part; ● at $ 0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” (as defined above) of our Common Stock; ● if, and only if, the closing price of our Common Stock equals or exceeds $ 10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of our Common Stock for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $ 18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The Private Placement Warrants were initially issued in the same form as the Public Warrants with the exception that the Private Warrants: (i) would not be redeemable by the Company and (ii) may be exercised for cash or on a cashless baseless so long as they are held by the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. The Public Warrants were initially classified as a derivative liability instrument. Upon the closing of the Business Combination, the Public Warrants in accordance with the guidance contained in ASC 815 are no longer precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. The Company continues to recognize the Private Placement Warrants as liabilities at fair value as of the Closing Date, with an offsetting entry to additional paid-in capital and adjusts the carrying value of the instruments to fair value through other income (expense) on the condensed consolidated statement of operations and comprehensive income (loss) at each reporting period until they are exercised. As of March 31, 2025, the Private Placement Warrants are presented within warrants on the condensed consolidated balance sheet. Private Veea Warrants Upon the closing of the Business Combination, the Related Party Common Stock Warrants were exercised in whole, on a net basis, for 3,880,000 shares of common stock of Private Veea at a conversion price of $ 0.01 per share for an aggregate purchase price of $ 38,800 . A total of 21,798 shares of common stock were surrendered in payment of the purchase price. 16 In connection with the Business Combination, Private Veea’s outstanding equity-classified Preferred stock warrants were exchanged for common stock warrants of the Company (each an “Exchanged Warrant”) to purchase a number of shares of Common Stock, after adjustment for anti-dilutive shares, equal to the product of (i) the number of shares of Private Veea’s common stock subject to such Preferred Stock warrant immediately prior to the Business Combination and (ii) the Exchange Ratio, at an exercise price per share equal to (A) the exercise price per share of such Preferred Stock warrant immediately prior to the consummation of the Business Combination, divided by (B) the Exchange Ratio. On November 6, 2024, the warrant holder exercised warrants to purchase 79,654 shares of Common Stock at an exercise price of $ 0.05 per share for an aggregate purchase price of $ 3,983 . The outstanding Exchanged Warrants are exercisable at the option of the holder until September 28, 2028, for an exercise price of $ 10.19 per share. As of March 31, 2025, there are 159,307 Exchanged Warrants outstanding. 12 - RELATED PARTY TRANSACTIONS Lease Agreements On March 1, 2014, Private Veea entered into a sublease agreement with NLabs Inc., an affiliate of the Company’s CEO that held approximately 33 % of the Company’s outstanding capital stock at December 31, 2024, for office space for an initial term of five years . In 2018, Private Veea renewed the sublease for an additional five-year term, with all other terms and conditions of the sublease remaining the same. The renewal term expired February 28, 2024, and was subsequently extended to December 31, 2025. Rent for the office space is accrued and not paid in cash. The Company recognized rent expense of $ 61,200 for each of the three months ended March 31, 2025 and 2024, which was classified as general and administrative expenses in the Company’s condensed consolidated statements of operations and comprehensive income (loss). Accrued and unpaid rent expense included in the Company’s condensed consolidated balance sheets was $ 1,774,800 as of March 31, 2025 and $ 1,713,600 as of December 31, 2024. In April 2017, Private Veea entered into a lease agreement with 83 rd Street LLC to lease office space for an initial term of two years . The sole member of 83 rd Street LLC is the Salmasi 2004 Trust. At December 31, 2024, the Salmasi 2004 Trust held approximately 8 % of Veea’s outstanding capital stock. Veea’s CEO is the grantor of the Salmasi 2004 Trust. In 2018, Private Veea renewed the lease for an additional five-year term, with all other terms and conditions of the lease remaining the same. The renewal term expired February 28, 2024, and was subsequently extended to December 31, 2025. Rent for the office space is accrued and not paid in cash. The Company recognized rent expense of $ 72,000 for each of the three months ended March 31, 2025, which is classified as general and administrative expenses in the Company’s condensed consolidated statements of operations and comprehensive income (loss). Accrued and unpaid rent expense included in the Company’s condensed consolidated balance sheets was $ 2,016,000 and $ 1,944,000 as of March 31, 2025 and December 31, 2024, respectively. Related Party Debt In 2021 and 2022, NLabs made loans to the Company evidenced by promissory notes aggregating $ 9,500,000 (the “Bridge Notes”). The Bridge Notes bore interest on the outstanding principal at a rate of 10 % per annum, calculated on the basis of a 365-day year. The original maturity date of the Bridge Notes was December 31, 2022, which was extended to December 31, 2023, which was subsequently extended to September 30, 2024. The Company accounted for the extension as a modification of the Bridge Notes. The unpaid principal amount and accrued unpaid interest on the Bridge Notes was due and payable upon the date of the first to occur of (i) the maturity date and (ii) the consummation of a debt or equity financing transaction with an unrelated third party. Interest expense for the three months ended March 31, 2024 was $ 237,500 . In 2022 and 2023, NLabs made loans to the Company evidenced by promissory notes in the aggregate principal amount of $ 3,098,000 (the “Promissory Notes” and collectively with the Bridge Notes, the “Related Party Notes”). The Promissory Notes bore interest on the outstanding principal amount at a rate of 10 % per annum, calculated on the basis of a 365-day year. The unpaid principal amount and accrued interest on the Promissory Notes was due and payable upon the earlier of demand and December 31, 2023, which was subsequently extended to September 30, 2024. Interest expense for the three months ended March 31, 2024 was $ 57,963 . 17 At the Closing in September 2024, the Related Party Notes were converted into shares of Common Stock at a price of $ 5.00 per share, which shares were not considered Existing Veea Shares and were in addition to the shares of Common Stock issued to holders of Existing Veea Shares. Thus, there was no interest expense recorded for the three months ended March 31, 2025, for the Related Party Notes. See Note 4 for further information regarding the conversion of the Related Party Notes. During the three months ended March 31, 2025, NLabs made loans to the Company in the aggregate amount of $ 485,000 (the “March NLabs Notes”). Interest on the loans accrue at a rate of 10 % per annum, calculated on the basis of a 365-day year. Principal and accrued interest is payable on the earlier of demand or June 30, 2025. In April 2025, NLabs made additional loans in the aggregate amount of $ 341,000 (collectively with the March NLabs Notes, the “2025 NLabs Notes”). 13 - COMMITMENTS AND CONTINGENCIES Purchase Commitments with Contract Manufacturers and Suppliers As of March 31, 2025, the Company had no unconditional purchase obligations for the purchase of goods or services from suppliers and contract manufacturers. Unconditional purchase obligations are obligations that are enforceable and legally binding on the Company and specify all significant terms, including quantities to be purchased, fixed, minimum or variable price provisions and the approximate timing of the transaction. Unconditional purchase obligations exclude agreements that are cancellable without penalty. Leases The Company leases office space in the U.S., including office space from related parties as disclosed in Note 12. These leases expire at various dates through 2025. Under the terms of the various lease agreements, the Company may bear certain costs such as maintenance, insurance and taxes. Lease agreements may provide for increasing rental payments at fixed intervals. The Company’s CEO has guaranteed the obligations under the office space leased in New Jersey. The Company also leases offices in the United Kingdom, France, and Mexico under short-term arrangements of twelve months or less. Indemnifications In the normal course of business, the Company has indemnification obligations to other parties, including customers, lessors, and parties to other transactions with us, with respect to certain matters. The Company has agreed to indemnify against losses arising from a breach of representations or covenants or out of intellectual property infringement or other claims made against certain parties. These agreements may limit the time or circumstances within which an indemnification claim can be made and the amount of the claim. It is not possible to determine the maximum potential amount for claims made under the indemnification obligations due to uncertainties in the litigation process, coordination with and contributions by other parties and the defendants in these types of cases, and the unique facts and circumstances involved in each particular case and agreement. To date, the Company has made no indemnity payments. In addition, the Company has entered into indemnification agreements with its officers and directors, and its Amended and Restated Bylaws contain similar indemnification obligations to its agents. 18 Litigation In the normal course of business, the Company may become involved in various lawsuits and legal proceedings. The Company accrues contingent liabilities when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. While the ultimate results of these matters cannot be predicted with certainty, management does not expect them to have a material adverse effect on the financial position or results of operations of the Company. Other Commitments In connection with the Business Combination, the Company agreed to pay certain legal expenses contingent upon the closing of the Business Combination, certain of which expenses were mutually agreed to be deferred to periods after the Closing. As of March 31, 2025, the amount of the deferred fees totaled $ 2.2 million, recorded in deferred payables, current in the condensed consolidated balance sheet. 14 - FAIR VALUE MEASUREMENTS Recurring Fair Value Measurements Warrant liability The Company’s initial value of the warrant liability was based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets and classified as level 3. The subsequent measurement of the Private Warrants is classified as Level 2 because these warrants are economically equivalent to the Public Warrants, based on the terms of the Private Warrant agreement, and as such their value is principally derived by the value of the Public Warrants. Significant deviations from these estimates and inputs could result in a material change in fair value. During the three months ended March 31, 2025, there were no transfers amongst level 1, 2, and 3 values during the period. The conversion feature of the Convertible Promissory Notes is measured at fair value using a Monte Carlo model that fair values the conversion option. The following table presents fair value information as of March 31, 2025 and December 31, 2024, of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. March 31, 2025 Total Level 1 Level 2 Level 3 Private warrant liability $ 420,497 $ 420,497 Convertible note option liability 1,000 1,000 Earn-out share liability 5,030,000 5,030,000 Total $ 5,451,497 $ $ 420,497 $ 5,031,000 December 31, 2024 Total Level 1 Level 2 Level 3 Assets Money Market Funds $ - $ - $ - $ - Liabilities Private warrant liability 840,995 - 840,995 - Convertible note option liability 60,000 - - 60,000 Earn-out Share Liability 15,560,000 - - 15,560,000 Total $ 16,460,995 $ - $ 840,995 $ 15,620,000 Convertible Note Option Liability The Company established the initial fair value for the convertible note option liability as of September 13, 2024, which was the date the Convertible Note was executed. As of March 31, 2025, the fair value was remeasured using an option pricing model. The option pricing model was used to value the convertible note option liability for the initial periods and subsequent measurement periods. 19 The convertible note option liability was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. The key inputs into the option pricing model for the convertible note option liability were as follows: March 31, 2025 December 31, 2024 Stock Price $ 1.49 $ 3.81 Expected term (years) 0.95 1.2 Volatility 80.0 % 75.0 % Risk-Free Rate 4.05 % 4.18 % Interest rate 6.41 % 6.49 % Three months ended March 31, 2025 Balance, beginning of period $ 60,000 Change in fair value ( 59,000 ) Balance, end of period $ 1,000 Earn-out Share Liability Following the closing of the Business Combination, holders of certain capital stock of Private Veea immediately prior to the closing have the contingent right to receive up to 4.5 million additional shares of Common Stock if certain trading-price based milestones of the Common Stock are achieved or a change of control transaction occurs during the ten-year period following the Closing. The Company’s obligation to issue the earn out shares is recorded as a contingent liability (the “Earn-out Share Liability”) in the Company’s financial statements. The initial value of the contingent Earn-out Share Liability of $ 53.6 million was recorded as a transaction cost within operating expenses. The fair value of the Earn-out Share Liability was estimated using a Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility, the price of the Common Stock, and current interest rates. The following table presents the changes in fair value of the earn-out liability: Three months ended March 31, 2025 Balance, beginning of period $ 15,560,000 Change in fair value ( 10,530,000 ) Balance, end of period $ 5,030,000 The key inputs for the Earn-out Share Liability were as follows: March 31, 2025 December 31, 2024 Stock Price $ 1.49 $ 6.5 Expected term (years) 9.5 10 Volatility 75 % 75.0 % Risk-Free Rate 4.2 % 3.81 % 20 15 - EARNINGS PER SHARE The computation of basic and dilutive net loss per share attributable to common stockholders for the three months ended March 31, 2025 and 2024, are as follows: Three Months ended March 31, 2025 2024 Basic: Numerator: Net income (loss) attributable to common shareholders $ 4,299,052 $ ( 6,547,412 ) Denominator: Weighted-average common shares outstanding 36,369,224 21,115,617 Net income (loss) per share – basic: $ 0.12 $ ( 0.31 ) Diluted: Numerator: Net income (loss) attributable to common and common equivalent shareholders 4,299,052 ( 6,547,412 ) Denominator: Weighted-average common stock outstanding 36,369,224 21,115,617 Stock options, warrants, Earn-Out Liability, and convertible notes outstanding to purchase shares of common stock 214,441 - Total common and common equivalent shares outstanding 36,583,665 21,115,617 Net income (loss) per share – diluted: $ 0.12 $ ( 0.31 ) The weighted average potential shares of common stock that were excluded from the calculation of net income (loss) per share-diluted for the periods presented because including them would have been anti-dilutive consisted of the following: Three Months ended March 31, 2025 2024 Stock options outstanding to purchase shares of common stock 4,145,706 - Public and Private Warrants 11,799,851 - Earn-Out Liability 4,500,000 - 16 - EMPLOYEE 401(k) PLAN The Company sponsors a 401(k) plan (the “Plan”) to provide retirement benefits for its employees. As allowed under Section 401(k) of the Internal Revenue Code, the Plan provides for tax-deferred salary contributions and after-tax contributions for eligible employees. The Plan provides for tax-deferred salary contributions and after-tax contributions for eligible employees. Employee contributions are limited to a maximum annual amount as set periodically by the Internal Revenue Code. The Company matches pretax and Roth employee contributions up to 4 % of eligible earnings that are contributed by employees. All matching contributions vest immediately. The Company’s matching contributions to the Plan for the three months ended March 31, 2025 and 2024, totaled $ 37,240 and $ 40,553 , respectively. 17 - SUBSEQUENT EVENTS The Company evaluated subsequent events from March 31, 2025, the date of these financial statements, through the date on which the financial statements were issued (the “Issuance Date”), for events requiring recording or disclosure in the financial statements as of and for the three months ended March 31, 2025. The Company concluded that no events have occurred that would require recognition or disclosure in the financial statements, except as described below. Asset Purchase Transaction with Crowdkeep, Inc. Asset Purchase Agreement On May 13, 2025, the Company entered into an Asset Purchase Agreement (the “APA”) with Crowdkeep, Inc., a Delaware corporation (the “Seller”), pursuant to which, subject to the terms and conditions set forth in the APA, the Company acquired, upon the closing (the “Crowdkeep Closing”, and the date of such Crowdkeep Closing, the “Crowdkeep Closing Date”) certain assets of Seller relating to Seller’s IoT technology platform business (collectively, the “Crowdkeep Assets”), free and clear of any liens other than certain specified liabilities of Seller that are being assumed (collectively, the “Crowdkeep Liabilities” and such acquisition of the Crowdkeep Assets and assumption of the Crowdkeep Liabilities together, the “Crowdkeep Transaction”) in consideration for the issuance to the Seller of 4,065,689 shares of Common Stock (the “Purchase Price”). The APA contains other customary representations, warranties and covenants of the parties. The foregoing summary of the APA is not complete and is qualified in its entirety by reference to the full text of the APA, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference. 21 Note Purchase Agreements and Convertible Promissory Notes On April 17, 2025, and May 13, 2025, the Company and the majority stockholder of the Seller (“Crowdkeep Investor”), entered into two Note Purchase Agreements (the “Crowdkeep Note Purchase Agreements”). Pursuant to the Crowdkeep Note Purchase Agreements, the Crowdkeep Investor loaned to the Company an aggregate of $ 1,000,000 in two tranches (the “Crowdkeep Loans”), of which $ 500,000 was provided on April 17, 2025 and $ 500,000 was provided on May 13, 2025. In connection with the entry into the Crowdkeep Note Purchase Agreements the Company issued to the Crowdkeep Investor unsecured convertible promissory notes (the “Crowdkeep Convertible Notes”). The Crowdkeep Convertible Notes have an aggregate principal amount of $ 1,000,000 , and the interest under the Crowdkeep Convertible Notes accrues at an annual rate of 8 %. The maturity date of the Crowdkeep Convertible Notes are April 17, 2026, and May 13, 2026, respectively. Pursuant to the terms of the Convertible Notes, upon an event of default, the outstanding principal amount of the applicable Crowdkeep Convertible Note, plus accrued but unpaid interest, will become immediately due and payable in full. Events of default include failure to pay any principal or interest amounts under the Crowdkeep Convertible Notes, failure to perform covenants in the Crowdkeep Convertible Notes and certain bankruptcy and insolvency conditions of the Company. The Company may prepay all or any portion of the Crowdkeep Convertible Notes at any time. The Crowdkeep Convertible Notes are convertible, in whole or in part, into shares of Common Stock (the “Crowdkeep Conversion Shares”) at the option of the Crowdkeep Investor, at a price per share of $ 5.00 subject to certain equitable adjustments. The Crowdkeep Convertible Notes will automatically convert on the date that the closing price of the Common Stock is at $ 7.50 or above for ten (10) consecutive trading days within any consecutive thirty (30) trading day period, equal to the lesser of (i) $7.50 per share and (ii) 20% multiplied by the VWAP (calculated as set forth in the Crowdkeep Convertible Notes) for the prior consecutive thirty (30) trading day period, in each case subject to certain equitable adjustments. The Crowdkeep Note Purchase Agreements and Crowdkeep Convertible Notes include other customary terms and conditions. The above description of the Crowdkeep Note Purchase Agreements and Crowdkeep Convertible Notes are qualified in their entirety by the text of the Form of Note Purchase Agreement and Form of Convertible Note, copies of which are attached hereto as Exhibit 10.2 and 10.3, respectively, and incorporated herein by reference. Lock-Up Agreements In connection with the Crowdkeep APA and the Crowdkeep Note Purchase Agreements, the Seller and the Crowdkeep Investor entered into lock-up agreements pursuant to which the Seller and the Crowdkeep Investor agreed not to effect any sale, distribution or transfer of any of the shares of Common Stock received in the transaction or any Crowdkeep Conversion Shares will be subject to transfer restrictions and restrictions against selling short or hedging the Company’s securities for a period of six (6) months following the applicable closing of the APA or the Crowdkeep Note Purchase Agreement, respectively, subject to certain limited exceptions. The form of lock-up agreement signed by the Seller is herein referred to as the “Crowdkeep Lock-Up Agreement” and the form of lock-up agreement signed by the Investor is herein referred to as the “Crowdkeep Noteholder Lock-Up Agreement.” The Crowdkeep Lock-Up Agreement and the Crowdkeep Noteholder Lock-Up Agreement have substantially similar terms, but the Crowdkeep Lock-Up Agreement provides for distributions by the Seller to the Seller’s stockholders, pro rata based on their ownership of Seller, subject to certain conditions. The foregoing description of the Crowdkeep Lock-Up Agreement and Crowdkeep Noteholder Lock-Up Agreement do not purport to be complete and are qualified in its entirety by the terms and conditions of the form of Crowdkeep Lock-Up Agreement and form of Crowdkeep Noteholder Lock-Up Agreement, copies of which are attached hereto as Exhibit 10.4 and Exhibit 10.5, respectively, and are incorporated herein by reference. Appointment of Chief Strategy Officer and Senior Vice President, Finance On May 1, 2025, Randal V. Stephenson was appointed the Company’s Senior Vice President, Finance and Chief Strategy Officer. 22